Table 2. Characteristics of patients who, at follow-up, had either progressed their liver fibrosis stage (progressors) or their liver fibrosis stage had remained the same or reversed (non-progressors)

Characteristics	Progressors( n = 11, 18.7%)	Non-progressors( n = 48, 81.3%)	P value
Male sex, n (%)	6	54.5	32	66.7	0.478^a
Median age, years (IQR)	58	48–67	57	51–65	0.917^b
BAME ethnic group, n (%)	2	18.2	8	16.7	0.927^a
T2DM positive, n (%)	9	81.8	25	52.1	0.083^a
Fibroscan readings:
Mean baseline kPa (SD)	7.2	0.8	7.7	1.7	0.024^b
Mean follow-up kPa (SD)	13.6	3.8	6.1	1.9	0.007^b
Mean change in kPa between baseline and follow-up (SD)	6.4	3.5	–1.5	2.0	0.041^b
BMI (kg/m²)
Median baseline (IQR)	33.6	28.5–39.4	32.0	27.5–35.4	0.189^b
Median follow-up (IQR)	33.3	28.7–37.3	30.5	26.3–36.6	0.706^b
Mean time interval between scans, months (SD)	52.5	2.9	53.9	3.4	0.164^b
Alcohol AUDIT grade:^c
Baseline high, n (%)^d	2	18.2	16	33.3	0.287^a
Follow-up high, n (%)^d	4	36.4	18	38.3	0.866^a

^a P values refer to a χ2 test of independence using an alpha level of 5%^{. b} P values refer to a two-tailed independent samples t-test using a confidence interval of 95%. ^cTwo patients are excluded from the alcohol AUDIT grade change as they declined to complete the questionnaire at follow-up. ^dHigh = hazardous, harmful, and dependent alcohol AUDIT grades. BAME = Black and minority ethnic. BMI = body mass index. T2DM = type 2 diabetes mellitus.